Among the immune stimulators, the expression level of CD276, CD40, CD80, CXCR4, ENTPD1, MICB, PDCD1LG2, TNFRSF14, and TNFSF13B was significantly increased in GBM samples compared to nontumor samples (Figure 6A). This evidence concerns the gene TNFSF13B and glioblastoma.